Upgrade to SI Premium - Free Trial

Atea Pharmaceuticals Inc. (AVIR)

5.83 +0.01 (0.17%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Atea Pharmaceuticals (AVIR) PT Raised to $7 at Morgan Stanley August 13, 2026 8:08 AM - StreetInsider Form 10-Q Atea Pharmaceuticals, For: Jun 30 August 12, 2026 4:46 PM - SEC Filing Form 8-K Atea Pharmaceuticals, For: Aug 12 August 12, 2026 4:16 PM - SEC Filing Aviragen Therapeutics (AVIR) Tops Q2 EPS by 15c August 12, 2026 4:14 PM - StreetInsider Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update August 12, 2026 4:05 PM - Globe NewsWire Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026 August 5, 2026 7:00 AM - Globe NewsWire Atea Pharmaceuticals HCV drug meets phase 3 trial endpoints July 28, 2026 7:00 AM - StreetInsider Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus July 28, 2026 7:00 AM - Globe NewsWire Atea Pharmaceuticals starts Phase 1 trial of AT-587 for hepatitis E July 14, 2026 7:00 AM - StreetInsider Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus July 14, 2026 7:00 AM - Globe NewsWire Atea Pharmaceuticals completes enrollment in phase 3 HCV trial June 25, 2026 7:01 AM - StreetInsider Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus June 25, 2026 7:00 AM - Globe NewsWire Form 4 Atea Pharmaceuticals, For: Jun 18 Filed by: Lucidi Bruno June 23, 2026 5:00 PM - SEC Filing Form 4 Atea Pharmaceuticals, For: Jun 18 Filed by: BERGER FRANKLIN M June 23, 2026 5:00 PM - SEC Filing Form 4 Atea Pharmaceuticals, For: Jun 18 Filed by: Berman Howard June 23, 2026 5:00 PM - SEC Filing Form 4 Atea Pharmaceuticals, For: Jun 18 Filed by: KIRSCH ARTHUR S June 23, 2026 5:00 PM - SEC Filing Form 4 Atea Pharmaceuticals, For: Jun 18 Filed by: Murphy Polly A. June 23, 2026 5:00 PM - SEC Filing Form 4 Atea Pharmaceuticals, For: Jun 18 Filed by: Adams Jerome M. June 23, 2026 5:00 PM - SEC Filing Form 4 Atea Pharmaceuticals, For: Jun 18 Filed by: DUNCAN BARBARA GAYLE June 23, 2026 5:00 PM - SEC Filing Form 4 Atea Pharmaceuticals, For: Jun 18 Filed by: Polsky Bruce June 23, 2026 5:00 PM - SEC Filing Form 8-K Atea Pharmaceuticals, For: Jun 18 June 22, 2026 4:54 PM - SEC Filing Full Article List